About: Altinicline

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Altinicline (SIB-1508Y, SIB-1765F) is a drug which acts as an agonist at neural nicotinic acetylcholine receptors with high selectivity for the α4β2 subtype. It stimulates release of dopamine and acetylcholine in the brain in both rodent and primate models, and progressed as far as Phase II clinical trials for Parkinson's disease, where "no antiparkinsonian or cognitive-enhancing effects were demonstrated", although its current status is unclear.

Property Value
dbo:abstract
  • Altinicline (SIB-1508Y, SIB-1765F) is a drug which acts as an agonist at neural nicotinic acetylcholine receptors with high selectivity for the α4β2 subtype. It stimulates release of dopamine and acetylcholine in the brain in both rodent and primate models, and progressed as far as Phase II clinical trials for Parkinson's disease, where "no antiparkinsonian or cognitive-enhancing effects were demonstrated", although its current status is unclear. (en)
dbo:casNumber
  • 179120-92-4
dbo:chEMBL
  • 111659
dbo:fdaUniiCode
  • RJ9V9V09VM
dbo:pubchem
  • 3036156
dbo:thumbnail
dbo:wikiPageID
  • 24509259 (xsd:integer)
dbo:wikiPageLength
  • 3395 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1123032390 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • None (en)
dbp:c
  • 12 (xsd:integer)
dbp:casNumber
  • 179120 (xsd:integer)
dbp:chembl
  • 111659 (xsd:integer)
dbp:chemspiderid
  • 2300234 (xsd:integer)
dbp:h
  • 14 (xsd:integer)
dbp:iupacName
  • -3 (xsd:integer)
dbp:molecularWeight
  • 186.252000 (xsd:double)
dbp:n
  • 2 (xsd:integer)
dbp:pubchem
  • 3036156 (xsd:integer)
dbp:smiles
  • c2ncccc2C1CCCN1C (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • NUPUDYKEEJNZRG-LBPRGKRZSA-N (en)
dbp:unii
  • RJ9V9V09VM (en)
dbp:verifiedrevid
  • 437196684 (xsd:integer)
dbp:width
  • 175 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Altinicline (SIB-1508Y, SIB-1765F) is a drug which acts as an agonist at neural nicotinic acetylcholine receptors with high selectivity for the α4β2 subtype. It stimulates release of dopamine and acetylcholine in the brain in both rodent and primate models, and progressed as far as Phase II clinical trials for Parkinson's disease, where "no antiparkinsonian or cognitive-enhancing effects were demonstrated", although its current status is unclear. (en)
rdfs:label
  • Altinicline (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License